Press Releases
FamilieSCN2A Foundation Announces 2025 Action Potential and Accelerator Award Recipients
August 19, 2025
FamilieSCN2A Foundation Expands Multidisciplinary Care with Children's Hospital Colorado Neurogenetics Clinic
February 24, 2025
FamilieSCN2A and Cellectricon Partner to Accelerate Drug Development for a Top Autism and Epilepsy Gene, SCN2A
February 24, 2025
New Study in Journal, Brain, Reveals Expanded Clinical Phenotype Spectrum in SCN2A-related disorders
April 26, 2024
FamilieSCN2A Foundation Partners with NORD® to Initiate Registry for SCN2A-related disorders
March 7, 2024
FamilieSCN2A Foundation Partners with UTHealth Houston on First Multidisciplinary Center for SCN2A-Related Disorders
February 29, 2024
FamilieSCN2A Partners with C-Path’s RDCA-DAP, Advancing Research Efforts for SCN2A-Related Disorders
February 1, 2024
FamilieSCN2A Foundation Announces Third Hodgkin-Huxley Funding Award of 2023 to Danish Researcher Rikke Møller, PhD
October 11, 2023
FamilieSCN2A Foundation Awards Prestigious Hodgkin-Huxley Grant to Dr. Kevin Bender to Advance SCN2A Therapeutic Metrics
September 13, 2023
FamilieSCN2A Foundation Announces Inaugural $2.5M Hodgkin-Huxley Research Award
May 9, 2023
Key Publications
Read key publications that summarize the clinical picture and highlight research advances in SCN2A-related disorders.